MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. Cost of Revenue
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) reported Cost of Revenue of $42.63 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-29.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-04-29
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-12-31 | $42.63M 20-F · filed 2026-04-29 | |
| 2025-06-30 | $25.37M 6-K · filed 2025-09-18 | |
| 2024-12-31 | $63.61M 20-F · filed 2026-04-29 | |
| 2024-06-30 | $30.16M 6-K · filed 2025-09-18 | |
| 2023-12-31 | $63.90M 20-F · filed 2026-04-29 | |
| 2023-06-30 | $31.02M 6-K · filed 2024-09-20 | |
| 2022-12-31 | $65.25M 20-F · filed 2025-04-25 | |
| 2022-06-30 | $33.94M 6-K · filed 2023-10-02 | |
| 2021-12-31 | $64.23M 20-F · filed 2024-04-24 | |
| 2020-12-31 | $51.90M 20-F/A · filed 2023-08-29 | |
| 2019-12-31 | $47.42M 20-F · filed 2022-07-29 |